Emerson Electric Co. ( NYSE: EMR) Q2 2025 - Earnings Conference Call May 7, 2025 8:30 AM ET Colleen Mettler - Vice President-Investor Relations Lal Karsanbhai - President and Chief Executive Officer ...

Continuous glucose monitoring provides a new, less invasive method for evaluating diabetes risk. Fluctuations in blood glucose are more than just daily energy swings—they may hold the key to ...

For years, metformin has been the go-to first-line oral medication for patients newly diagnosed with type 2 diabetes. But ...

Soleno Therapeutics, Inc. (Soleno) (NASDAQ: SLNO), a biopharmaceutical company developing novel therapeutics for the ...

Julie Dewey; Chief Investor Relations and Communications Officer; Orthofix Medical Inc. Massimo Calafiore; President, Chief Executive Officer; Orthofix Medical Inc.